These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2185106)

  • 1. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.
    McCulloch DK; Klaff LJ; Kahn SE; Schoenfeld SL; Greenbaum CJ; Mauseth RS; Benson EA; Nepom GT; Shewey L; Palmer JP
    Diabetes; 1990 May; 39(5):549-56. PubMed ID: 2185106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of beta-cell function in insulin autoantibody-positive relatives of insulin-dependent diabetic patients.
    Neifing JL; Greenbaum CJ; Kahn SE; McCulloch DK; Barmeier H; Lernmark A; Palmer JP
    Metabolism; 1993 Apr; 42(4):482-6. PubMed ID: 8487672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetic determinants and prediction of IDDM in French schoolchildren.
    Lévy-Marchal C; Dubois F; Noël M; Tichet J; Czernichow P
    Diabetes; 1995 Sep; 44(9):1029-32. PubMed ID: 7657024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
    Greenbaum CJ; Sears KL; Kahn SE; Palmer JP
    Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus: beta-cell function, islet cell antibody, and haptoglobin in parents of IDDM patients.
    Kajio H; Kobayashi T; Nakanishi K; Okubo M; Tsukada T; Nakayama T; Yamada N; Murase T; Yazaki Y; Kosaka K
    Metabolism; 1995 Jul; 44(7):869-75. PubMed ID: 7616845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
    Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
    Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients.
    Robert JJ; Deschamps I; Chevenne D; Roger M; Mogenet A; Boitard C
    Diabetes Care; 1991 Aug; 14(8):718-23. PubMed ID: 1954807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes.
    Kobayashi T; Itoh T; Kosaka K; Sato K; Tsuji K
    Diabetes; 1987 Apr; 36(4):510-7. PubMed ID: 3545950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.
    Ongagna JC; Levy-Marchal C
    Diabetologia; 1995 Mar; 38(3):370-5. PubMed ID: 7758886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
    Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
    J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
    Christie MR; Roll U; Payton MA; Hatfield EC; Ziegler AG
    Diabetes Care; 1997 Jun; 20(6):965-70. PubMed ID: 9167107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM.
    Pugliese A; Gianani R; Moromisato R; Awdeh ZL; Alper CA; Erlich HA; Jackson RA; Eisenbarth GS
    Diabetes; 1995 Jun; 44(6):608-13. PubMed ID: 7789622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
    Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell autoimmunity and progression to insulin-dependent diabetes mellitus in genetically high- and low-risk siblings of diabetic children. The Childhood Diabetes in Finland (DiMe) Study Group.
    Karjalainen J; Vähasalo P; Knip M; Tuomilehto-Wolf E; Virtala E; Akerblom HK
    Eur J Clin Invest; 1996 Aug; 26(8):640-9. PubMed ID: 8872058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M; Karjalainen J; Akerblom HK
    Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic, immunologic, and environmental heterogeneity of IDDM. Incidence and 12-mo follow-up of an Italian population.
    Pagano G; Cavallo-Perin P; Cavalot F; Dall'Omo AM; Masciola P; Suriani R; Amoroso A; Curtoni SE; Borelli I; Lenti G
    Diabetes; 1987 Jul; 36(7):859-63. PubMed ID: 3556283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decrease of early insulin secretion, risk factor of insulin-dependent diabetes. Prospective study in families with diabetic children].
    Robert JJ; Boitard C; Mogenet A; Chevenne D; Roger M; Deschamps I
    Arch Fr Pediatr; 1991 Jan; 48(1):11-7. PubMed ID: 2018414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus.
    Chaillous L; Rohmer V; Maugendre D; Lecomte P; Maréchaud R; Marre M; Guilhem I; Charbonnel B; Saï P
    Metabolism; 1996 Mar; 45(3):306-14. PubMed ID: 8606636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.